Cargando…
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide
OBJECTIVES: To evaluate the potential prognostic utility of pretreatment systemic immune-inflammation index (SII) in newly diagnosed glioblastoma multiforme (GBM) patients who underwent postneurosurgical radiotherapy and concurrent plus adjuvant temozolomide. METHODS: The retrospective data of GBM p...
Autores principales: | Topkan, Erkan, Besen, Ali Ayberk, Ozdemir, Yurday, Kucuk, Ahmet, Mertsoylu, Huseyin, Pehlivan, Berrin, Selek, Ugur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262659/ https://www.ncbi.nlm.nih.gov/pubmed/32565725 http://dx.doi.org/10.1155/2020/4392189 |
Ejemplares similares
-
Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide
por: Topkan, Erkan, et al.
Publicado: (2020) -
Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol
por: Topkan, Erkan, et al.
Publicado: (2020) -
Pretreatment Photopenia on (18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2020) -
Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients
por: Topkan, Erkan, et al.
Publicado: (2019) -
The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2023)